NSE · ZYDUSLIFE
Zydus Lifesciences Limited
₹1,167.30
-3.13%
Market Cap
117,430.38 Cr
P/E Ratio
23.30
P/B Ratio
3.97
ROE
17.32%
ROCE
20.65%
Dividend Yield
—
52W High
₹1,205.00
52W Low
₹855.95
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 8,017.00 Cr | 7,587.00 Cr | 6,864.50 Cr | 6,123.20 Cr |
| Net Profit | 990.20 Cr | 1,341.00 Cr | 1,022.90 Cr | 1,238.60 Cr |
| EPS | 9.35 | 12.65 | 10.36 | 12.51 |
| Operating Profit | 1,480.80 Cr | 2,180.20 Cr | 1,568.20 Cr | 1,822.90 Cr |
Shareholding pattern
Shareholding pattern for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.